Monday, January 28, 2019

[ASAP] Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1a Inhibitor Impairs Pancreatic Tumor Growth

TOC Graphic

ACS Nano
DOI: 10.1021/acsnano.8b08823


from ACS Nano: Latest Articles (ACS Publications) http://bit.ly/2FSLgAt
via IFTTT

No comments:

Post a Comment